Chief Executive Officer:
Jeff Marquass (PGDipBA), a 30-year veteran of the medical device and pharmaceutical sectors. Mr Marquass has held senior management roles in large multinational companies for the last 22 years such as Wyeth, Pfizer, Clearlab and most recently 5 years as a Director of Hoya (Surgical Optics). Mr. Marquass leadership approach has always been focused on bringing the best out of people by nurturing and supporting open thinking and proactive interaction. “One person can have an idea, but it takes many to make change.”
Steve Carroll (MSc, BSc, RFE, Dip DSMS, Dip IMT, Dip QM, Dip PMP, Dip NUT, Dip PT) is a wireless communications specialist and an ISSA certified nutritionist. He formed part of the GEC teams that won two major international awards for science and innovation in the 1990’s. He has developed multivariate products including military radios, mobile telephones and missile guidance systems for the UK Ministry of Defence and NATO. Steve is fully conversant with aged and contemporary mobile protocols including GSM, GPRS, UMTS, CDMA, LTE, 2, 3, 4 and 5G. He regularly consults for a UK CBD entity and is seeking to break new-ground in the research of Cannabacea. In 2020, Steve was assigned as the sole inventor of a revolutionary burns dressing for wound-care and gained an affiliate certification from Harvard Medical University USA for Nutritional Science.
Chief Business Officer:
Siebren Kamphorst (B.Corpfin) has over a decade’s worth of experience as a specialist in contract review, contract negotiation, project management, business strategy and commercial analysis. Mr Siebren started his career working for a major logistics company in the Netherlands, and subsequently held senior positions in numerous multinational organisations in the energy, logistics, property, and telecommunications sectors. He has been involved in large-scale projects across the world, some of which include the installation and hook-up of various oil and gas platforms across Asia.
Chief Science Officer:
David Newman (B.Sc., MBMS) has a strong background in biomedical research and a keen acumen for business. Mr. Newman’s was an indispensable member in starting up an international distributing company for the PG Bugatti bicycles. Mr. Newman also has ample experience in organising laboratory operations, experiments, and research projects efficiently to meet set goals using methodical and sound scientific approaches.
Dominick Muermans (IGCSEs, I.B., HRD, IGI, IBM) is a business development specialist with vast experience in developing and trading real estate, international dealings, and business development. Some previous experiences include being responsible for international licenses and sales of energy drink Transatlantic Blow from 2007 to 2009 and while undertaking a managerial position for Greenway Nutrients from 2009 to 2015. He also was advisor to the board of Sintagma holdings in Mozambique from 2015 to 2020 and assists with the business development for GH medical from 2017 to present. His latest position is as an investor and director of Trilogy Capital Group and heads up the Africa metals & gem trading as well as the business development side of the firm from 2012 to present.
Business Development Director: